ALX Oncology (ALXO): A Rising Star in the US Stocks up in the pre-market
ALX Oncology, a clinical-stage immuno-oncology company’s stock has been on a surge in the premarket session today, making it a focal point for investors and market analysts alike. In the pre-market session, the stock demonstrated exceptional performance, with its price skyrocketing to $9.96, reflecting an